Literature DB >> 1759087

Type-oriented therapy for gastric cancer effective for lymph node metastasis: management of lymph node metastasis using activated carbon particles adsorbing an anticancer agent.

T Takahashi1, K Sawai, A Hagiwara, S Takahashi, K Seiki, H Tokuda.   

Abstract

Activated carbon particles are taken selectively up by lymphatics when injected into the tissues and visualize regional lymph nodes colored black. Furthermore, carbon particles adsorb a large amount of the anticancer agent mitomycin C (MMC) on their surface and release the drug reversibly. Using these properties of activated carbon particles, we have applied it for lymph node dissection and chemotherapy of lymph node metastasis. After injection of carbon particles, regional lymph nodes of the stomach were found to be black; blackened lymph nodes extending widely from perigastric to para-aortic nodes were identified from other structures. Four hundred and twenty-four patients with gastric cancer were treated with this method for lymph node metastasis during 1984-1988. Involved nodes were generally colored in high incidence, about 70% of involved ones except for highly positive nodes, which was the same as noninvolved nodes. In highly positive nodes, the colored incidence was decreased to about 48%. The cumulative 5-year survival rate of the patients treated with this series was 74.6%, which was significantly higher than the figures without this method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759087     DOI: 10.1002/ssu.2980070610

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  9 in total

1.  Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients.

Authors:  Toshiyuki Kosuga; Daisuke Ichikawa; Kazuma Okamoto; Shuhei Komatsu; Atsushi Shiozaki; Hitoshi Fujiwara; Eigo Otsuji
Journal:  Gastric Cancer       Date:  2011-02-18       Impact factor: 7.370

2.  Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience.

Authors:  Alberto Di Leo; Daniele Marrelli; Franco Roviello; Marco Bernini; AnnaMaria Minicozzi; Simone Giacopuzzi; Corrado Pedrazzani; Luca Gian Baiocchi; Giovanni de Manzoni
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

3.  Metastatic lymph node in gastric cancer; is it a real distant metastasis?

Authors:  Do Hyoung Lim; Hyeong Su Kim; Young Suk Park; Jeeyun Lee; Se Hoon Park; Ho Yeong Lim; Sang Hoon Ji; Min Jae Park; Seong Yoon Yi; Ji Yeong An; Tae Sung Sohn; Jae Hyoung Noh; Jae Moon Bae; Sung Kim; Cheol Keun Park; Won Ki Kang
Journal:  BMC Cancer       Date:  2010-01-29       Impact factor: 4.430

4.  Priority of lymph node dissection for proximal gastric cancer invading the greater curvature.

Authors:  Yukio Maezawa; Toru Aoyama; Takanobu Yamada; Kazuki Kano; Tsutomu Hayashi; Tsutomu Sato; Takashi Oshima; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Haruhiko Cho; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2017-11-08       Impact factor: 7.370

5.  The Role of No. 10 Lymphadenectomy for Advanced Proximal Gastric Cancer Patients Without Metastasis to No. 4sa and No. 4sb Lymph Nodes.

Authors:  Shibo Bian; Hongqing Xi; Xiaosong Wu; Jianxin Cui; Liangang Ma; Rong Chen; Bo Wei; Lin Chen
Journal:  J Gastrointest Surg       Date:  2016-03-03       Impact factor: 3.452

6.  Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma.

Authors:  E Otsuji; T Yamaguchi; K Sawai; K Okamoto; T Takahashi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Efficacy of the No. 10 lymphadenectomy with spleen preservation on patients with gastric cancer and/or esophagogastric junction adenocarcinoma who underwent total gastrectomy: a systematic review and meta-analysis.

Authors:  Bo-Wei Xia; Chen Wang; Yong-Yong Liu; Yong Fan; Xiao-Dong He; Ying-Xin Kang; Xin-Yuan Zhou; Xiao-Lu Su; Yue-Bin Wang; Min-Xue Chen; Bo-Xiong Kang
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

8.  Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis.

Authors:  Jun Du; Yangchao Shen; Wenwu Yan; Jinguo Wang
Journal:  World J Surg Oncol       Date:  2020-09-01       Impact factor: 2.754

Review 9.  Advantages of Splenic Hilar Lymph Node Dissection in Proximal Gastric Cancer Surgery.

Authors:  Ali Guner; Woo Jin Hyung
Journal:  J Gastric Cancer       Date:  2020-03-20       Impact factor: 3.720

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.